450
Views
21
CrossRef citations to date
0
Altmetric
Drug Evaluations

Pasireotide for the treatment of acromegaly

&
Pages 579-588 | Received 14 Nov 2015, Accepted 20 Jan 2016, Published online: 17 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Elisa B. Lamback, Luiz Eduardo Wildemberg & Mônica R. Gadelha. (2021) Current opinion on the diagnosis and management of non-functioning pituitary adenomas. Expert Review of Endocrinology & Metabolism 16:6, pages 309-320.
Read now

Articles from other publishers (20)

Monica R. Gadelha & Leandro Kasuki. (2023) Refractory somatotroph adenomas. Pituitary 26:3, pages 266-268.
Crossref
Michelle Felicia Lee & Chit Laa Poh. (2023) Strategies to improve the physicochemical properties of peptide-based drugs. Pharmaceutical Research 40:3, pages 617-632.
Crossref
Lei Wang, Nanxi Wang, Zhibin Yan, Zhifeng Huang & Caiyun Fu. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery 795 815 .
Leandro Kasuki & Mônica R. Gadelha. (2022) Innovative therapeutics in acromegaly. Best Practice & Research Clinical Endocrinology & Metabolism 36:6, pages 101679.
Crossref
Julio Abucham. (2022) Dopaminergic treatment of patients with acromegaly: still kicking after all these years. Archives of Endocrinology and Metabolism 66:3, pages 275-277.
Crossref
Eva C Coopmans, Aart J van der Lely & Sebastian J C M M Neggers. (2022) Approach to the Patient With Treatment-resistant Acromegaly. The Journal of Clinical Endocrinology & Metabolism 107:6, pages 1759-1766.
Crossref
Lei Wang, Nanxi Wang, Wenping Zhang, Xurui Cheng, Zhibin Yan, Gang Shao, Xi Wang, Rui Wang & Caiyun Fu. (2022) Therapeutic peptides: current applications and future directions. Signal Transduction and Targeted Therapy 7:1.
Crossref
Monica R Gadelha, Luiz Eduardo Wildemberg & Leandro Kasuki. (2022) The Future of Somatostatin Receptor Ligands in Acromegaly. The Journal of Clinical Endocrinology & Metabolism 107:2, pages 297-308.
Crossref
Luiz Eduardo Wildemberg, Aline Helen da Silva Camacho, Renan Lyra Miranda, Paula C L Elias, Nina R de Castro Musolino, Debora Nazato, Raquel Jallad, Martha K P Huayllas, Jose Italo S Mota, Tobias Almeida, Evandro Portes, Antonio Ribeiro-OliveiraJr.Jr., Lucio Vilar, Cesar Luiz Boguszewski, Ana Beatriz Winter Tavares, Vania S Nunes-Nogueira, Tânia Longo Mazzuco, Carolina Garcia Soares Leães Rech, Nelma Veronica Marques, Leila Chimelli, Mauro Czepielewski, Marcello D Bronstein, Julio Abucham, Margaret de Castro, Leandro Kasuki & Mônica Gadelha. (2021) Machine Learning-based Prediction Model for Treatment of Acromegaly With First-generation Somatostatin Receptor Ligands. The Journal of Clinical Endocrinology & Metabolism 106:7, pages 2047-2056.
Crossref
You-Hyang Song, Jiwon Yoon & Seung-Hee Lee. (2021) The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders. Experimental & Molecular Medicine 53:3, pages 328-338.
Crossref
Eva C Coopmans, Ammar Muhammad, Aart J van der Lely, Joseph A M J L Janssen & Sebastian J C M M Neggers. (2019) How to Position Pasireotide LAR Treatment in Acromegaly. The Journal of Clinical Endocrinology & Metabolism 104:6, pages 1978-1988.
Crossref
Mônica R Gadelha, Leandro Kasuki, Dawn S T Lim & Maria Fleseriu. (2019) Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. Endocrine Reviews 40:1, pages 268-332.
Crossref
Luiz Eduardo Wildemberg, Leandro Kasuki & Mônica R. Gadelha. (2018) Precision medicine in the medical management of pituitary tumors. Current Opinion in Endocrine and Metabolic Research 1, pages 57-62.
Crossref
Leandro Kasuki, Luiz Eduardo Wildemberg & Mônica R Gadelha. (2018) MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly. European Journal of Endocrinology, pages R89-R100.
Crossref
Leandro Kasuki, Marília Duarte Dalmolin & Mônica Gadelha. 2018. Hypothalamic-Pituitary Diseases. Hypothalamic-Pituitary Diseases 61 91 .
Leandro Kasuki, Marília Duarte Dalmolin & Mônica Gadelha. 2017. Thyroid Diseases. Thyroid Diseases 1 31 .
Sarinj Fattah & David J Brayden. (2017) Progress in the formulation and delivery of somatostatin analogs for acromegaly. Therapeutic Delivery 8:10, pages 867-878.
Crossref
W K M G Amarawardena, K D Liyanarachchi, J D C Newell-Price, R J M Ross, D Iacovazzo & M Debono. (2017) Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly. Endocrinology, Diabetes & Metabolism Case Reports.
Crossref
Monica R. Gadelha, Luiz Eduardo Wildemberg, Marcello D. Bronstein, Federico Gatto & Diego Ferone. (2017) Somatostatin receptor ligands in the treatment of acromegaly. Pituitary 20:1, pages 100-108.
Crossref
Susan L. Samson. (2016) Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR. Drugs 76:13, pages 1235-1243.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.